Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Maravai LifeSciences Holdings Inc’s stock clocked out at $2.73, down -5.54% from its previous closing price of $2.89. In other words, the price has decreased by -$5.54 from its previous closing price. On the day, 1.19 million shares were traded. MRVI stock price reached its highest trading level at $2.85 during the session, while it also had its lowest trading level at $2.71.
Ratios:
To gain a deeper understanding of MRVI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.17 and its Current Ratio is at 5.96. In the meantime, Its Debt-to-Equity ratio is 1.09 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2025, Downgraded its rating to Neutral and sets its target price to $3 from $9 previously.
Goldman Downgraded its Neutral to Sell on December 05, 2024, while the target price for the stock was maintained at $4.25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 997389120 and an Enterprise Value of 672574784. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.87 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at 2.781 whereas that against EBITDA is -16.862.
Stock Price History:
The Beta on a monthly basis for MRVI is 0.29, which has changed by -0.68835616 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $10.03, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 20.74%, while the 200-Day Moving Average is calculated to be -35.81%.
Shares Statistics:
It appears that MRVI traded 1.85M shares on average per day over the past three months and 2257440 shares per day over the past ten days. A total of 143.96M shares are outstanding, with a floating share count of 103.47M. Insiders hold about 28.13% of the company’s shares, while institutions hold 77.27% stake in the company. Shares short for MRVI as of 1749772800 were 13048449 with a Short Ratio of 7.43, compared to 1747267200 on 14595684. Therefore, it implies a Short% of Shares Outstanding of 13048449 and a Short% of Float of 10.780000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
